San Diego-dependent Viking Therapeutics marked alone as a significant competitor inside the weight loss drug marketplace in February soon after revealing promising facts from a mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when given to be a weekly injection and in March the company … Read More